Benjamin L. Barthel
Impact in
-
- Cholinesterase and Neurodegenerative Diseases
- Pharmacogenetics and Drug Metabolism
-
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Cancer therapeutics and mechanisms 3
- Muscle Physiology and Disorders 2
- Enzyme function and inhibition 2
-
- Cholinesterase and Neurodegenerative Diseases 2
- Pharmacogenetics and Drug Metabolism 1
- Co-authors
- Tad H. Koch (9 shared papers)David J. Burkhart (4 shared papers)Lori D. Dwyer‐Nield (1 shared paper)Alvin M. Malkinson (1 shared paper)Bradley S. Barrett (1 shared paper)Alison K. Bauer (1 shared paper)Lori R. Kisley (1 shared paper)Amy M. Meyer (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (6 papers)Molecular Pharmaceutics (1 paper)Biochemical Pharmacology (1 paper)Annals of Clinical and Translational Neurology (1 paper)Topics in current chemistry (1 paper)
- Partner nations
- United StatesUnited KingdomTaiwan
In The Last Decade
Benjamin L. Barthel
13 papers receiving 364 citations
Peers
Comparison fields: 5 of 81
- Pharmacology 61
- Cancer Research 49
- Pharmacology 26
- Biomaterials 41
- Biochemistry 21
Countries citing papers authored by Benjamin L. Barthel
This map shows the geographic impact of Benjamin L. Barthel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin L. Barthel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin L. Barthel more than expected).
Fields of papers citing papers by Benjamin L. Barthel
This network shows the impact of papers produced by Benjamin L. Barthel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin L. Barthel. The network helps show where Benjamin L. Barthel may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin L. Barthel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Genetic ablation of inducible nitric oxide synthase decreases mouse lung tumorigenesis. | 2002 | 102 |
| 2 | 2006 | 40 | |
| 3 | 2012 | 38 | |
| 4 | 2005 | 36 | |
| 5 | 2008 | 29 | |
| 6 | 2012 | 29 | |
| 7 | 2009 | 24 | |
| 8 | 2017 | 20 | |
| 9 | 2021 | 16 | |
| 10 | 2016 | 15 | |
| 11 | 2007 | 14 | |
| 12 | 2020 | 10 | |
| 13 | 2025 | 2 |
About Benjamin L. Barthel
Benjamin L. Barthel is a scholar working on Molecular Biology, Pharmacology, Organic Chemistry, Cardiology and Cardiovascular Medicine and Oncology, having authored 13 papers that have together received 375 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Cancer therapeutics and mechanisms (3 papers), Muscle Physiology and Disorders (2 papers), Cholinesterase and Neurodegenerative Diseases (2 papers), Cancer Treatment and Pharmacology (2 papers), Synthesis and Biological Evaluation (2 papers), Enzyme function and inhibition (2 papers) and Pharmacogenetics and Drug Metabolism (1 paper). The work is most often cited by research in Pharmacology (61 citations), Cancer Research (49 citations), Pharmacology (26 citations), Biomaterials (41 citations) and Biochemistry (21 citations). Benjamin L. Barthel has collaborated with scholars based in United States, United Kingdom and Taiwan. Frequent co-authors include Tad H. Koch, David J. Burkhart, Lori D. Dwyer‐Nield, Alvin M. Malkinson, Bradley S. Barrett, Alison K. Bauer, Lori R. Kisley, Amy M. Meyer, David C. Thompson and J.R. Hagadorn. Their work appears in journals such as Journal of Medicinal Chemistry, Molecular Pharmaceutics, Biochemical Pharmacology, Annals of Clinical and Translational Neurology and Topics in current chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.